Variant report
Variant | nsv970821 |
---|---|
Chromosome Location | chr7:39854417-39856931 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr7:39855994-39856041 | Pancreas_OC | pancreas: | n/a | n/a |
2 | GATA2 | chr7:39856063-39856582 | SH-SY5Y | brain: | n/a | n/a |
3 | GATA3 | chr7:39855956-39856620 | SK-N-SH | brain: | n/a | n/a |
4 | GATA3 | chr7:39855973-39856400 | T-47D | breast: | n/a | n/a |
5 | GATA3 | chr7:39855827-39856654 | SH-SY5Y | brain: | n/a | n/a |
6 | GATA3 | chr7:39856003-39856553 | SK-N-SH | brain: | n/a | n/a |
7 | NFIC | chr7:39856138-39856726 | SK-N-SH | brain: | n/a | n/a |
8 | RCOR1 | chr7:39856461-39856489 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:39849762..39852736-chr7:39853685..39855413,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDK13-6 | chr7:39856148-39856291 | NONHSAT120234 |
2 | lnc-CDK13-6 | chr7:39856418-39856575 | NONHSAT120234 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237251 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs60571161 | chr7:39854437-39854438 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs545069589 | chr7:39854488-39854489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551423875 | chr7:39854492-39854493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368646020 | chr7:39854521-39854522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78992317 | chr7:39854526-39854527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148586150 | chr7:39854573-39854574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550881047 | chr7:39854588-39854589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560722533 | chr7:39854592-39854593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1016304 | chr7:39854599-39854600 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs546251282 | chr7:39854613-39854614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566235164 | chr7:39854627-39854628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538763272 | chr7:39854649-39854650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568066100 | chr7:39854684-39854685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141922288 | chr7:39854718-39854719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs367766993 | chr7:39854723-39854724 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568860943 | chr7:39854750-39854751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376100375 | chr7:39854755-39854756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537316426 | chr7:39854773-39854774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62453012 | chr7:39854834-39854835 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557701632 | chr7:39854890-39854891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541432507 | chr7:39854891-39854892 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377758772 | chr7:39854958-39854959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146127102 | chr7:39855011-39855012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556897283 | chr7:39855072-39855073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1016303 | chr7:39855140-39855141 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs57983731 | chr7:39855160-39855161 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs187845263 | chr7:39855186-39855187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575617986 | chr7:39855195-39855196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375285795 | chr7:39855209-39855210 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544146827 | chr7:39855229-39855230 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192953722 | chr7:39855235-39855236 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529794215 | chr7:39855239-39855240 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184119677 | chr7:39855388-39855389 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559947540 | chr7:39855393-39855394 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139849282 | chr7:39855400-39855401 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532083377 | chr7:39855404-39855405 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189497578 | chr7:39855433-39855434 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559823594 | chr7:39855487-39855488 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568723604 | chr7:39855521-39855522 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34763382 | chr7:39855532-39855533 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73687351 | chr7:39855559-39855560 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs200986702 | chr7:39855578-39855579 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73687366 | chr7:39855580-39855581 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs181903836 | chr7:39855581-39855582 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs202061239 | chr7:39855582-39855583 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553589591 | chr7:39855613-39855614 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73385762 | chr7:39855615-39855616 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs538730590 | chr7:39855725-39855726 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371870178 | chr7:39855737-39855738 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188989145 | chr7:39855738-39855739 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Gastric cancer | 24379144 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:39851000-39855200 | Weak transcription | Left Ventricle | heart |
2 | chr7:39851200-39855400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:39851400-39854800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr7:39853200-39854600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr7:39854600-39859200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr7:39854800-39855600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr7:39855000-39856800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr7:39855200-39856000 | Bivalent Enhancer | Adipose Nuclei | Adipose |
9 | chr7:39855400-39855600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr7:39855400-39855600 | Enhancers | Left Ventricle | heart |
11 | chr7:39855400-39856000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr7:39855600-39856200 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
13 | chr7:39855600-39856200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr7:39855600-39856600 | Bivalent Enhancer | Fetal Lung | lung |
15 | chr7:39856200-39856400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr7:39856200-39856400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr7:39856400-39856600 | Bivalent Enhancer | HUVEC | blood vessel |